Abcam (ABC) Sets New 52-Week High at $1,318.00

Abcam (LON:ABC) shares hit a new 52-week high during trading on Tuesday . The company traded as high as GBX 1,318 ($18.87) and last traded at GBX 1,310 ($18.76), with a volume of 582152 shares traded. The stock had previously closed at GBX 1,286 ($18.41).

A number of research analysts have issued reports on the company. Peel Hunt reiterated a “hold” rating on shares of Abcam in a research report on Wednesday, April 4th. JPMorgan Chase boosted their price target on Abcam from GBX 946 ($13.55) to GBX 1,011 ($14.48) and gave the stock a “neutral” rating in a research report on Thursday, March 15th. Berenberg Bank lowered Abcam to a “hold” rating and cut their price objective for the company from GBX 1,240 ($17.75) to GBX 1,230 ($17.61) in a report on Monday, March 5th. Finally, Numis Securities upgraded Abcam to a “buy” rating and set a GBX 1,200 ($17.18) price objective for the company in a report on Friday, January 5th. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of GBX 1,018.50 ($14.58).

The business also recently announced a dividend, which was paid on Thursday, April 12th. Stockholders of record on Thursday, March 15th were issued a dividend of GBX 3.42 ($0.05) per share. This represents a dividend yield of 0.28%. The ex-dividend date was Thursday, March 15th.

ILLEGAL ACTIVITY NOTICE: This report was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at

About Abcam

Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, and tools and reagents.

Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with's FREE daily email newsletter.

Leave a Reply